APA (7th ed.) Citation

NM, B., SB, B., LA, H., Y, H., PK, K., JW, M., . . . S, V. (2005). Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: Four-year results of an open-label extension of 2 randomized clinical trials: TAP Report No. 7. Archives of ophthalmology (Chicago, Ill. : 1960), 123(9), 1283. https://doi.org/10.1001/archopht.123.9.1283

Chicago Style (17th ed.) Citation

NM, Bressler, et al. "Verteporfin Therapy for Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration: Four-year Results of an Open-label Extension of 2 Randomized Clinical Trials: TAP Report No. 7." Archives of Ophthalmology (Chicago, Ill. : 1960) 123, no. 9 (2005): 1283. https://doi.org/10.1001/archopht.123.9.1283.

MLA (9th ed.) Citation

NM, Bressler, et al. "Verteporfin Therapy for Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration: Four-year Results of an Open-label Extension of 2 Randomized Clinical Trials: TAP Report No. 7." Archives of Ophthalmology (Chicago, Ill. : 1960), vol. 123, no. 9, 2005, p. 1283, https://doi.org/10.1001/archopht.123.9.1283.